DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock
$7,18
Prix · Aoû 19, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$5–$18
15% of range
Note des analystes
SELL
10 analysts
Objectif de cours
$7
P/E (TTM)
-1.3
ROE
-55.8%
Marge nette
-183.8%
À propos de Ginkgo Bioworks Holdings, Inc. Class A Common Stock Présentation de l'entreprise depuis Wikipedia
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Lire la suite
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
DNA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$7.18
Capitalisation Boursière
$443M
P/E (TTM)
-1.3
BPA (TTM)
$-5.64
Revenus (TTM)
$170M
Rendement div.
—
ROE
-55.8%
Dette/Capitaux propres
—
Fourchette 52 semaines
$5 – $18
DNA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$170M
2019-12-31
→
2025-12-31
BPA
$-5.64
2019-12-31
→
2025-12-31
Flux de trésorerie libre
$-179M
2022-12-31
→
2025-12-31
Marges
-183.8%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
DNA
Médiane des pairs
P/E (TTM)
-1.3
17.5
P/S (TTM)
2.6
3.3
P/B
0.9
2.1
Price / FCF (Cours / FCF)
-2.5
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
DNA
Médiane des pairs
Operating Margin (Marge d'exploitation)
-185.3%
—
Net Profit Margin (Marge nette)
-183.8%
-56.5%
ROA
-25.1%
-17.2%
ROE
-55.8%
-41.3%
ROIC
-61.8%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
DNA
Médiane des pairs
Current Ratio (Ratio de liquidité)
4.9
4.9
Quick Ratio (Ratio de liquidité réduite)
4.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
DNA
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-25.1%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-29.1%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
17.3%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
DNA
Médiane des pairs
DNA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
VENTE
10 analystes
- Achat fort 0 0,0%
- Achat 1 10,0%
- Conserver 2 20,0%
- Vente 5 50,0%
- Vente forte 2 20,0%
Objectif de cours à 12 mois
2 analystes · 2026-08-15
Médiane
$7.00
Maintenant
$7.18
Bas
$5.00
Haut
$9.00
Objectif médian
$7.00
-2,5%
Objectif moyen
$7.00
-2,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.05%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.75 | $-0.92 | 0.17% |
| 31 mars 2026 | $-1.39 | $-1.09 | -0.30% |
| 31 décembre 2025 | $-1.41 | $-1.47 | 0.06% |
| 30 septembre 2025 | $-1.45 | $-1.25 | -0.20% |
| 30 juin 2025 | $-1.10 | $-1.58 | 0.48% |
| 31 mars 2025 | $-1.68 | $-1.79 | 0.11% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Flux de trésorerie 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,827,409 | 52,240,559 | 51,370,029 | 50,111,460 | -3,848,559,493 | 48,770,000 | 1,933,437,000 | 1,914,963,000 | -3,211,245,963 | 1,630,911,000 | |
| Shares (Diluted) | · | · | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,860,455 | 52,246,129 | 51,375,599 | 50,133,366 | -3,850,233,493 | 48,770,000 | 1,933,437,000 | 1,916,637,000 | -3,211,226,528 | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $118M | $146M | · | $226M | $243M | $232M | · | $239M | $230M | $255M | · | $283M | $372M | $460M | · | $457M | |
| Net Income TTM | $-270M | $-315M | · | $-288M | $-425M | $-530M | · | $-742M | $-859M | $-847M | · | $-1.35B | $-1.72B | $-2.13B | · | $-2.03B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.9 | -1.2 | · | -2.7 | -1.4 | -0.6 | · | -0.5 | -1.0 | -4.8 | · | -10.6 | -72.9 | -40.9 | · | -98.3 | |
| P/S | 5.4 | 2.6 | · | 3.7 | 2.6 | 1.3 | · | 1.8 | 120.7 | 370.6 | · | 504.5 | 390.6 | 223.6 | · | 450.1 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| P / FCF | · | -7.8 | · | · | · | -5.3 | · | · | · | -983.2 | · | · | · | -935.1 | · | · | |
| Earnings Yield | -53.6% | -86.6% | · | -36.4% | -71.9% | -180.9% | · | -182.1% | -103.7% | -21.0% | · | -9.4% | -1.4% | -2.4% | · | -1.0% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $170M | $227M | $251M | $478M | $314M |
| Marge d'exploitation % | -185.3% | -246.5% | -343.8% | -462.4% | — |
| Résultat net | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| BPA dilué | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 4.9 | 5.6 | 6.1 | 8.4 | — |
| Ratio de liquidité réduite | 4.7 | 5.4 | 5.9 | 8.1 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-179M | $-382M | $-336M | $-304M | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Les "Magnificent Seven" : le titre favori de Cathie Wood actuellement
- Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
- This Warren Buffett Stock Is Beating the S&P 500 in 2026
- Californien Attorney General poursuit Chrome Holding pour la violation de données de 2023 de 23andMe
- Publicités pour kits d'auto‑prélèvement ADN interdites pour information trompeuse
- Jim Cramer sur BillionToOne : « Je dis acheter »
- Comment un coup de soleil a inspiré une nouvelle façon de stocker l'énergie
- Des vendeurs de marijuana poursuivis pour ne pas avoir averti les consommateurs des risques
- En hausse de 30% en 1 mois, le Zcash est-il un meilleur achat que le Bitcoin ?
- SCHQ vs. TLT : Même ADN obligations du Trésor, coûts et échéances très différents
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 204 déclarants · $269.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 39 (+13 vs T. préc.) | 17 (-11 vs T. préc.) | 65 (+23 vs T. préc.) | 35 (-12 vs T. préc.) | +6.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $35 449 338 | 3 577 128 | 13,18% | Actions |
| Erste Asset Management GmbH | $25 902 147 | 2 536 939 | 9,63% | Actions |
| BAILLIE GIFFORD & CO | $23 701 242 | 2 391 649 | 8,81% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $20 685 074 | 2 087 293 | 7,69% | Actions |
| Anchorage Capital Group, L.L.C. | $17 306 457 | 1 746 363 | 6,43% | Actions |
| STATE STREET CORP | $14 591 187 | 1 472 370 | 5,43% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $10 292 812 | 1 038 369 | 3,83% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 293 628 | 937 803 | 3,46% | Actions |
| Allianz Asset Management GmbH | $7 787 258 | 785 798 | 2,90% | Actions |
| MILLENNIUM MANAGEMENT LLC | $6 329 279 | 638 676 | 2,35% | Actions |
| SB INVESTMENT ADVISERS (UK) LTD | $6 052 324 | 610 729 | 2,25% | Actions |
| Prescott Group Capital Management, L.L.C. | $5 369 684 | 541 845 | 2,00% | Actions |
| GOLDMAN SACHS GROUP INC | $5 364 154 | 541 287 | 1,99% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $5 349 973 | 539 856 | 1,99% | Actions |
| BANK OF AMERICA CORP /DE/ | $4 760 754 | 480 399 | 1,77% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 109 677 | 414 700 | 1,53% | Option d'achat |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 910 555 | 394 607 | 1,45% | Actions |
| EXCHANGE TRADED CONCEPTS, LLC | $3 555 540 | 358 783 | 1,32% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $3 480 392 | 351 200 | 1,29% | Actions |
| TUDOR INVESTMENT CORP ET AL | $3 326 886 | 335 710 | 1,24% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $3 097 598 | 312 573 | 1,15% | Actions |
| Coastal Bridge Advisors, LLC | $2 743 256 | 276 817 | 1,02% | Actions |
| BALANCE CAPITAL PARTNERS L.P. | $1 972 179 | 199 009 | 0,73% | Actions |
| ALGERT GLOBAL LLC | $1 784 395 | 180 060 | 0,66% | Actions |
| Susquehanna Portfolio Strategies, LLC | $1 746 449 | 176 231 | 0,65% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $1 637 935 | 165 281 | 0,61% | Actions |
| PEAK6 LLC | $1 619 294 | 163 400 | 0,60% | Option d'achat |
| CAXTON ASSOCIATES LLP | $1 532 552 | 154 647 | 0,57% | Actions |
| D. E. Shaw & Co., Inc. | $1 499 938 | 151 356 | 0,56% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1 387 400 | 140 000 | 0,52% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 297 219 | 130 900 | 0,48% | Option de vente |
| CITADEL ADVISORS LLC | $1 233 973 | 124 518 | 0,46% | Actions |
| JPMORGAN CHASE & CO | $1 154 383 | 113 064 | 0,43% | Actions |
| a16z Capital Management, L.L.C. | $1 075 909 | 108 568 | 0,40% | Actions |
| CITADEL ADVISORS LLC | $1 073 253 | 108 300 | 0,40% | Option d'achat |
| Numerai GP LLC | $1 036 606 | 104 602 | 0,39% | Actions |
| AMERICAN CENTURY COMPANIES INC | $974 718 | 98 357 | 0,36% | Actions |
| WOLVERINE TRADING, LLC | $964 467 | 72 900 | 0,36% | Option d'achat |
| Ensign Peak Advisors, Inc | $931 332 | 93 979 | 0,35% | Actions |
| Bank of New York Mellon Corp | $818 843 | 82 628 | 0,30% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $803 592 | 81 089 | 0,30% | Actions |
| MARSHALL WACE, LLP | $772 356 | 77 937 | 0,29% | Actions |
| Swiss National Bank | $744 865 | 75 163 | 0,28% | Actions |
| ALLSTATE CORP | $698 209 | 70 455 | 0,26% | Actions |
| Mariner, LLC | $667 488 | 67 359 | 0,25% | Actions |
| IEQ CAPITAL, LLC | $624 766 | 63 044 | 0,23% | Actions |
| ALLEN OPERATIONS LLC | $613 935 | 61 951 | 0,23% | Actions |
| RHUMBLINE ADVISERS | $610 615 | 61 617 | 0,23% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $609 079 | 61 461 | 0,23% | Actions |
| TWO SIGMA INVESTMENTS, LP | $599 099 | 60 454 | 0,22% | Actions |
| BROWN ADVISORY INC | $586 731 | 59 206 | 0,22% | Actions |
| BlackRock, Inc. | $526 895 | 53 168 | 0,20% | Actions |
| EDGEWOOD MANAGEMENT LLC | $495 500 | 50 000 | 0,18% | Actions |
| WOLVERINE TRADING, LLC | $492 156 | 37 200 | 0,18% | Option de vente |
| Quadrature Capital Ltd | $456 732 | 46 088 | 0,17% | Actions |
| MORGAN STANLEY | $447 427 | 45 149 | 0,17% | Actions |
| Shay Capital LLC | $444 384 | 44 842 | 0,17% | Actions |
| LPL Financial LLC | $427 257 | 43 114 | 0,16% | Actions |
| CITIGROUP INC | $426 893 | 43 077 | 0,16% | Actions |
| JANE STREET GROUP, LLC | $414 238 | 41 800 | 0,15% | Option d'achat |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $387 709 | 39 123 | 0,14% | Actions |
| Casdin Capital, LLC | $361 646 | 36 493 | 0,13% | Actions |
| CITADEL ADVISORS LLC | $347 841 | 35 100 | 0,13% | Option de vente |
| Dynamic Technology Lab Private Ltd | $347 000 | 34 996 | 0,13% | Actions |
| ALLIANCEBERNSTEIN L.P. | $342 005 | 55 792 | 0,13% | Actions |
| GROUP ONE TRADING LLC | $326 138 | 32 910 | 0,12% | Actions |
| AlphaQuest LLC | $309 788 | 37 279 | 0,12% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $301 532 | 30 427 | 0,11% | Actions |
| Welch & Forbes LLC | $297 300 | 30 000 | 0,11% | Actions |
| MetLife Investment Management, LLC | $285 111 | 28 770 | 0,11% | Actions |
| AXQ CAPITAL, LP | $262 387 | 26 477 | 0,10% | Actions |
| BARCLAYS PLC | $258 919 | 26 127 | 0,10% | Actions |
| IMC-Chicago, LLC | $240 922 | 24 311 | 0,09% | Actions |
| Man Group plc | $239 901 | 24 208 | 0,09% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $238 425 | 24 059 | 0,09% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $222 975 | 22 500 | 0,08% | Actions |
| Russell Investments Group, Ltd. | $222 885 | 22 491 | 0,08% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $217 356 | 21 933 | 0,08% | Actions |
| Modera Wealth Management, LLC | $216 316 | 21 828 | 0,08% | Actions |
| MARTINGALE ASSET MANAGEMENT L P | $209 062 | 21 096 | 0,08% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $203 116 | 22 345 | 0,08% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $189 123 | 30 852 | 0,07% | Actions |
| Walleye Capital LLC | $188 944 | 19 066 | 0,07% | Actions |
| Invesco Ltd. | $186 209 | 18 790 | 0,07% | Actions |
| Trexquant Investment LP | $178 420 | 18 004 | 0,07% | Actions |
| SIMPLEX TRADING, LLC | $178 330 | 17 995 | 0,07% | Actions |
| Comprehensive Financial Management LLC | $174 971 | 17 656 | 0,07% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $172 474 | 17 404 | 0,06% | Actions |
| Boston Standard Wealth Management, LLC | $164 995 | 15 165 | 0,06% | Actions |
| DEUTSCHE BANK AG\ | $163 763 | 16 525 | 0,06% | Actions |
| Creative Planning | $156 974 | 15 840 | 0,06% | Actions |
| Vanguard Global Advisers, LLC | $155 904 | 15 732 | 0,06% | Actions |
| Squarepoint Ops LLC | $155 478 | 15 689 | 0,06% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $153 664 | 15 506 | 0,06% | Actions |
| ExodusPoint Capital Management, LP | $148 343 | 14 969 | 0,06% | Actions |
| Police & Firemen's Retirement System of New Jersey | $146 420 | 14 775 | 0,05% | Actions |
| Entropy Technologies, LP | $138 423 | 13 968 | 0,05% | Actions |
| Green Alpha Advisors, LLC | $134 241 | 13 546 | 0,05% | Actions |
| VANGUARD GROUP INC | $130 733 | 15 732 | 0,05% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $127 690 | 12 885 | 0,05% | Actions |
Initiés de la société 17 initiés · 5 dirigeants · 13 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 juillet 2026 A | 3 894 680 | 0 | 0 | $0 |
| Steven P. Coen | Chief Financial Officer | 16 juillet 2026 M | 51 438 | 0 | 1 | $-5 941 |
| Mark E. Dmytruk | Chief Financial Officer | 20 mai 2025 M | 46 226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 juillet 2026 A | 12 374 544 | 0 | 0 | $0 |
| Marie E. Fallon | Chief Accounting Officer | 1 mai 2023 M | 183 010 | 0 | 0 | $0 |
| Sri Kosuri | Administrateur | 11 juin 2026 A | 24 067 | 0 | 0 | $0 |
| Ross Fubini | Administrateur | 11 juin 2026 A | 10 822 | 0 | 0 | $0 |
| Christian O Henry | Administrateur | 11 juin 2026 A | 24 310 | 0 | 2 | $-219 800 |
| Harry Sloan | Administrateur | 11 juin 2026 A | 271 418 | 0 | 0 | $0 |
| Shyam Sankar | Administrateur | 12 juin 2025 A | 72 372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Administrateur | 11 juin 2025 M | 15 003 | 0 | 0 | $0 |
| Myrtle S Potter | Administrateur | 11 juin 2025 M | 10 822 | 0 | 0 | $0 |
| Arie Belldegrun | Administrateur | 13 juin 2024 A | 194 925 | 0 | 0 | $0 |
| Reshma Kewalramani | Administrateur | 12 juin 2024 M | 186 002 | 0 | 0 | $0 |
| Marijn E Dekkers | Administrateur | 12 juin 2024 M | 386 480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Administrateur | 16 septembre 2021 D | 31 590 948 | 0 | 0 | $0 |
| Barry Canton | Détenteur de 10% | 28 juillet 2026 A | 12 374 544 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 février 2025 | 9,50% | Amendement | — | SEC |
| Jason Kelly ×4 dépôts | 14 février 2024 | — | Dépôt initial | — | SEC |
| Reshma Shetty, Bartholomew Canton ×4 dépôts | 14 février 2024 | — | Dépôt initial | — | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 dépôts | 4 mars 2022 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 33 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,84% | 321 721 NS | 30 avril 2026 | N-PORT |
| IDNA · iShares Trust | 0,44% | 101 324 SH | 8 août 2026 | Quotidien |
| IWC · iShares Trust | 0,09% | 161 981 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 187 206 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,03% | 368 167 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 91 425 NS | 31 mai 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41 498 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,03% | 442 118 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,01% | 1 226 249 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,01% | 18 139 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549 889 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274 008 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,01% | 2 005 NS | 31 mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 112 735 SH | 8 août 2026 | Quotidien |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 210 534 NS | 31 mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1 567 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 16 982 NS | 30 avril 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 584 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2 081 NS | 31 mai 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4 528 NS | 30 avril 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 mai 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 252 NS | 30 avril 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19 123 NS | 30 avril 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22 130 SH | 8 août 2026 | Quotidien |
| ITOT · iShares Trust | 0,00% | 66 432 SH | 8 août 2026 | Quotidien |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 26 477 NS | 31 mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3 795 NS | 30 avril 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 584 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1 182 NS | 30 avril 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 489 851 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 264 SH | 8 août 2026 | Quotidien |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 504 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 232 NS | 30 avril 2026 | N-PORT |